RECTIV Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Rectiv, and what generic alternatives are available?
Rectiv is a drug marketed by Abbvie and is included in one NDA.
The generic ingredient in RECTIV is nitroglycerin. There are thirty-six drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Rectiv
A generic version of RECTIV was approved as nitroglycerin by AM REGENT on May 24th, 1988.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for RECTIV?
- What are the global sales for RECTIV?
- What is Average Wholesale Price for RECTIV?
Summary for RECTIV
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 36 |
Clinical Trials: | 1 |
Patent Applications: | 3,060 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for RECTIV |
What excipients (inactive ingredients) are in RECTIV? | RECTIV excipients list |
DailyMed Link: | RECTIV at DailyMed |
![RECTIV drug patent expirations Drug patent expirations by year for RECTIV](/p/graph/s/t/RECTIV-patent-expirations.png)
![Drug Prices for RECTIV](/p/graph/drug-price/RECTIV.png)
![Drug Sales Revenue Trends for RECTIV](/p/graph/drug-sales-revenues/RECTIV.png)
Recent Clinical Trials for RECTIV
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Forest Laboratories | Phase 4 |
Pharmacology for RECTIV
Drug Class | Nitrate Vasodilator |
Physiological Effect | Vasodilation |
US Patents and Regulatory Information for RECTIV
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie | RECTIV | nitroglycerin | OINTMENT;INTRA-ANAL | 021359-001 | Jun 21, 2011 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for RECTIV
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbvie | RECTIV | nitroglycerin | OINTMENT;INTRA-ANAL | 021359-001 | Jun 21, 2011 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for RECTIV
See the table below for patents covering RECTIV around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Austria | 374607 | ⤷ Sign Up | |
South Korea | 100386525 | ⤷ Sign Up | |
Japan | H09504037 | ⤷ Sign Up | |
European Patent Office | 1051972 | Compositions de donneurs d'oxyde nitrique et méthode pour le traitement de troubles anaux (Nitric oxide donor composition and method for treatment of anal disorders) | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |